Loading clinical trials...
Loading clinical trials...
Low Doses of Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias
Conditions
Interventions
Alemtuzumab, Rituximab
Locations
1
Mexico
Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitario contra el Cancer
Monterrey, Nuevo León, Mexico
Start Date
August 1, 2008
Primary Completion Date
August 1, 2010
Completion Date
August 1, 2010
Last Updated
August 30, 2010
NCT04014413
NCT00508820
NCT00415532
NCT01988506
NCT00909077
NCT04071496
Lead Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions